Letter by Potter and Le Lorier Regarding Article, "Cardiovascular Outcomes and Mortality in Patients Using Clopidogrel With Proton Pump Inhibitors After Percutaneous Coronary Intervention or Acute Coronary Syndrome"

被引：1
|
作者：
Potter, Brian J. [1 ]
Le Lorier, Jaques [1 ]
机构：
[1] CHU Montreal, Ctr Rech, Pharmacoecon & Pharmacoepidemiol Res Unit, Montreal, PQ, Canada
来源：
CIRCULATION | 2010年 / 122卷 / 05期
关键词：
D O I：
10.1161/CIRCULATIONAHA.110.939991
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E414 / E414
页数：1
相关论文
共 50 条
  • [31] Letter by Neubeck et al Regarding Article, "Impact of Cardiac Rehabilitation on Mortality and Cardiovascular Events After Percutaneous Coronary Intervention in the Community"
    Neubeck, Lis
    Redfern, Julie
    Ben Freedman, S.
    CIRCULATION, 2011, 124 (22) : E572 - E572
  • [32] Response by Bagai et al to Letter Regarding Article, "Individualizing Duration of Dual Antiplatelet Therapy After Acute Coronary Syndrome or Percutaneous Coronary Intervention"
    Bagai, Akshay
    Bhatt, Deepak L.
    Verma, Subodh
    Mehta, Shamir R.
    CIRCULATION, 2016, 134 (15) : E334 - E335
  • [33] Patients' Perspectives With Acute Coronary Syndrome After Percutaneous Coronary Intervention
    Qin, Hong
    Mayer, Hanna
    Ozturk, Begum
    Eslam, Roza Badr
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2021, 17 (05): : 588 - 593
  • [34] Predictors of mortality in patients with acute coronary syndrome undergoing percutaneous coronary intervention
    Constantinides, SS
    Gieowarsingh, S
    Halim, M
    Been, M
    Shiu, MF
    HEART, 2003, 89 (10) : 1245 - 1246
  • [35] THE CARDIOVASCULAR OUTCOMES ASSOCIATED WITH CONCOMITANT USE OF CLOPIDOGREL AND PROTON PUMP INHIBITORS IN PATIENTS OF ACUTE CORONARY SYNDROME IN TAIWAN - A POPULATION-BASED COHORT STUDY
    Gau, C.
    Lin, C.
    Shen, L.
    Lin, F.
    Bai, C.
    Wang, C.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S8 - S9
  • [36] Prevalence and outcomes of prasugrel versus clopidogrel in patients with and without diabetes following percutaneous coronary intervention for acute coronary syndrome
    Faggioni, M.
    Chandrasekhar, J.
    Baber, U.
    Sartori, S.
    Aquino, M.
    Rao, S.
    Weintraub, W.
    Effron, M.
    Baker, B.
    Danias, G.
    Pocock, S.
    Kapadia, S.
    Toma, C.
    Mehran, R.
    Henry, T.
    EUROPEAN HEART JOURNAL, 2016, 37 : 379 - 379
  • [37] Impact of Coronary Dominance on In-Hospital Outcomes After Percutaneous Coronary Intervention in Patients With Acute Coronary Syndrome
    Kuno, Toshiki
    Numasawa, Yohei
    Miyata, Hiroaki
    Takahashi, Toshiyuki
    Sueyoshi, Kouichirnu
    Ohki, Takahiro
    Negishi, Koji
    Kawamura, Akio
    Kohsaka, Shun
    Fukuda, Keiichi
    CIRCULATION, 2013, 128 (22)
  • [38] Impact of Coronary Dominance on In-Hospital Outcomes after Percutaneous Coronary Intervention in Patients with Acute Coronary Syndrome
    Kuno, Toshiki
    Numasawa, Yohei
    Miyata, Hiroaki
    Takahashi, Toshiyuki
    Sueyoshi, Koichiro
    Ohki, Takahiro
    Negishi, Koji
    Kawamura, Akio
    Kohsaka, Shun
    Fukuda, Keiichi
    PLOS ONE, 2013, 8 (08):
  • [39] Using ultrasound radiomics to forecast adverse cardiovascular events in patients with acute coronary syndrome after percutaneous coronary intervention
    Wu, Shutian
    Liu, Biaohu
    Fan, Haiyun
    Zhong, Yuxin
    Yang, You
    Yao, Aling
    ECHOCARDIOGRAPHY-A JOURNAL OF CARDIOVASCULAR ULTRASOUND AND ALLIED TECHNIQUES, 2024, 41 (08):
  • [40] Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention
    Li, Yuzhuo
    Li, Jing
    Qiu, Miaohan
    Ma, Sicong
    Na, Kun
    Li, Xiaoying
    Qi, Zizhao
    Chen, Sanbao
    Li, Yi
    Han, Yaling
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2022, 99 : 1395 - 1402
12345